Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shoaib Dal"'
Publikováno v:
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Externí odkaz:
https://doaj.org/article/94b9dc694fd2435daca0fc3ecefe6c50
Publikováno v:
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Introduction Ocrelizumab is a recombinant humanised monoclonal antibody that selectively depletes CD20 expressing B lymphocytes. Ocrelizumab was approved in Australia for use in relapsing-remitting and primary-progressive multiple sclerosis in July 2
Autor:
Neil Mahant, Melissa Robbie, Florence C.F. Chang, Jane Nankervis, Shoaib Dal, Laura J. Williams, Naomi Fletcher, Tien Lee Ong, Hugo Morales-Briceño, Sangamithra Babu, Victor S.C. Fung, Andrew Martin
Publikováno v:
Parkinsonismrelated disorders. 86
Background Microscopic colitis is a form of inflammatory bowel disease characterized by profuse non-bloody watery diarrhea. Macroscopic abnormality is not present on colonoscopy, and it requires biopsy for diagnosis. Few cases have been attributed to
Autor:
Scott Whyte, Shoaib Dal
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:A12.2-A12
IntroductionWe describe two cases of valproate-induced parkinsonism, where the parkinsonian features develop after commencing valproate (VPA), in a time frame and manner well described by previous publications.1 In contrast to the published literatur
076 A rare case of anti-glutamate decarboxylase antibody syndrome presenting with recurrent vomiting
Autor:
Bill O’Brien, Shoaib Dal
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:A24.1-A24
IntroductionAnti-glutamte decarboxylase antibody (anti-GAD) has been linked with various neurological syndromes including stiff-person syndrome, limbic encephalopathy, cerebellar ataxia, eye movement disorders and epilepsy (collectively known as ‘a